Poland approves Tilray’s medical cannabis for pharmaceutical distribution
Poland approves Tilray’s medical cannabis for pharmaceutical distribution Tilray Brands Inc. announced that its medical cannabis division, Tilray Medical, has received approval to commercialize its Tilray branded medical cannabis products in Poland expanding its...
Tilray posts $434 million net loss for 2022
Tilray posts $434 million net loss for 2022 Tilray just posted $434 million net loss for its 2022 fiscal year. The net loss includes a $395 million noncash impairment charge “primarily impacting inventory, goodwill and other intangible assets.” On a Thursday...
TSX Struggles, Aurora Cannabis and Tilray Shares Dip
TSX Struggles, Aurora Cannabis and Tilray Shares Dip The Toronto Stock Exchange or TSX, Canada’s main stock index fell on Wednesday, weighed by weakness in health-care and technology shares amid growing fears that aggressive policy tightening by central banks to...
Legal Cannabis Market Continues Rapid Global Growth
Legal Cannabis Market Continues Rapid Global Growth The global cannabis market is continuing to grow rapidly thanks to increasing legalization and social adoption across the globe. According to a report by Vantage Market Research, revenue came in at US$12.8 billion in...
Tilray Stock falls as cannabis sector shrugs off MORE Act vote
Tilray Stock falls as cannabis sector shrugs off MORE Act vote NASDAQ:TLRY fell by 3.73% during Friday’s trading session. The MORE Act passes the floor vote in the House of Representatives. Tilray announces its earnings call will be on April 6th, 2022. NASDAQ:TLRY...
Try CanninBot with Algo Trading Alerts FREE!
Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.
$29 / month after 7-day trial.
Still unsure? Schedule demo at [email protected]
or call 720-254-1374
Try CanninBot with Algo Trading Alerts FREE!
Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.
$29 / month after 7-day trial.
Still unsure? Schedule demo at [email protected]
or call 720-254-1374